IN2012DN03632A - - Google Patents

Download PDF

Info

Publication number: IN2012DN03632A
Authority: IN; India
Prior art keywords: weight; amount; fos; present; inulin
Prior art date: 2009-11-12

Application number

Other languages

English (en)

Inventor

Zamzam Fariba Roughead

Jalil Benyacoub

Claudia Roessle

Jennifer Rae Mager

Julie Ann Swanson

Norman Alan Greenberg

Douglas Richard Bolster

Rodenas Clara Lucia Garcia

Florence Rochat

Original Assignee

Nestec Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-11-12

Filing date

2010-11-11

Publication date

2015-06-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43567734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN03632(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-11-11 Application filed by Nestec Sa filed Critical Nestec Sa

2015-06-26 Publication of IN2012DN03632A publication Critical patent/IN2012DN03632A/en

Links

229920001202 Inulin Polymers 0.000 abstract 2
150000004676 glycans Chemical class 0.000 abstract 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
229940029339 inulin Drugs 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
235000016709 nutrition Nutrition 0.000 abstract 2
229920001282 polysaccharide Polymers 0.000 abstract 2
239000005017 polysaccharide Substances 0.000 abstract 2
SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
229920000189 Arabinogalactan Polymers 0.000 abstract 1
239000001904 Arabinogalactan Substances 0.000 abstract 1
229920002907 Guar gum Polymers 0.000 abstract 1
235000019312 arabinogalactan Nutrition 0.000 abstract 1
239000000665 guar gum Substances 0.000 abstract 1
229960002154 guar gum Drugs 0.000 abstract 1
235000010417 guar gum Nutrition 0.000 abstract 1
244000005709 gut microbiome Species 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Pediatric Medicine (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Transplantation (AREA)

IN3632DEN2012 2009-11-12 2010-11-11 IN2012DN03632A (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US26049509P	2009-11-12	2009-11-12
US26443009P	2009-11-25	2009-11-25
US39480510P	2010-10-20	2010-10-20
PCT/US2010/056321 WO2011060123A1 (fr)	2009-11-12	2010-11-11	Composition nutritionnelle permettant de favoriser l'équilibre de microbiotes digestifs et la santé

Publications (1)

Publication Number	Publication Date
IN2012DN03632A true IN2012DN03632A (fr)	2015-06-26

Family

ID=43567734

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN3632DEN2012 IN2012DN03632A (fr)	2009-11-12	2010-11-11

Country Status (14)

Country	Link
US (2)	US9192179B2 (fr)
EP (1)	EP2498626B1 (fr)
JP (2)	JP6006117B2 (fr)
CN (2)	CN104206946A (fr)
AU (1)	AU2010319490B2 (fr)
BR (1)	BR112012011294B1 (fr)
CA (1)	CA2777941C (fr)
DK (1)	DK2498626T3 (fr)
ES (1)	ES2545597T3 (fr)
IN (1)	IN2012DN03632A (fr)
MX (1)	MX336032B (fr)
PH (1)	PH12012500687A1 (fr)
RU (1)	RU2012123959A (fr)
WO (1)	WO2011060123A1 (fr)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6006117B2 (ja) *	2009-11-12	2016-10-12	ネステクソシエテアノニム	腸内微生物叢バランス及び健康を促進するための栄養組成物
MY191538A (en) *	2010-12-31	2022-06-30	Abbott Lab	Human milk oligosaccharides to promote growth of beneficial bacteria
CA2839524C (fr)	2011-06-20	2016-05-17	H.J. Heinz Company	Methodes et compositions probiotiques
WO2012175639A1 (fr) *	2011-06-22	2012-12-27	Universite De Rouen	Protéines arabinogalactanes pour l'utilisation en tant qu'agent antiparasitaire
FI126711B (fi) *	2011-10-12	2017-04-13	Gut Guide Oy	Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
ES2559381T3 (es)	2011-10-18	2016-02-11	Nestec S.A.	Composición para su uso en la promoción del crecimiento de hueso sano y/o en la prevención y/o tratamiento de osteopatía
TW201318566A (zh) *	2011-11-01	2013-05-16	呂健民	膳食補充劑組合物及其用於調控血糖之方法
WO2013130773A2 (fr)	2012-02-29	2013-09-06	Ethicon Endo-Surgery, Inc.	Compositions de microbiota et leurs procédés associés
ITRM20120084A1 (it)	2012-03-07	2013-09-08	Aboca Spa Societa Agricola	Miscela prebiotica.
WO2014007606A1 (fr)	2012-07-05	2014-01-09	N.V. Nutricia	Produit pour l'utilisation dans le traitement prophylactique ou thérapeutique d'une émotion négative ou d'un comportement introverti
JP2015535280A (ja) *	2012-11-01	2015-12-10	レイクスユニフェルシテイトフローニンゲン	胃腸管において有益な細菌を刺激する方法及び組成物
NZ709392A (en)	2012-11-23	2016-10-28	Seres Therapeutics Inc	Synergistic bacterial compositions and methods of production and use thereof
US8906668B2 (en)	2012-11-23	2014-12-09	Seres Health, Inc.	Synergistic bacterial compositions and methods of production and use thereof
US20150296851A1 (en) *	2012-11-27	2015-10-22	Shanghai Jiao Tong University	Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
EP3904502A3 (fr)	2013-02-04	2022-02-23	Seres Therapeutics, Inc.	Compositions et procédés
US11185562B2 (en)	2013-02-04	2021-11-30	Seres Therapeutics, Inc.	Compositions and methods for inhibition of pathogenic bacterial growth
EP2983662A4 (fr) *	2013-03-15	2016-09-21	MicroBiome Therapeutics LLC	Fibre de cosse de soja activée
HK1220326A1 (zh)	2013-03-15	2017-05-05	Seres Therapeutics, Inc.	基於网络微生物组成和方法
GB201312713D0 (en) *	2013-03-22	2013-08-28	Weaver Connie M	Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB201305708D0 (en) *	2013-03-28	2013-05-15	Clasado Inc	Novel use
US20160051468A1 (en) *	2013-04-11	2016-02-25	Bright Drinks Inc.	Compositions for Prevention and/or Treatment of Gastrointestinal Imbalances in Digestive Disorders
ITMI20131467A1 (it) *	2013-09-06	2015-03-07	Sofar Spa	Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MX367109B (es)	2013-11-25	2019-08-05	Seres Therapeutics Inc	Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
WO2015095241A2 (fr)	2013-12-16	2015-06-25	Seres Health, Inc.	Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire
CN105828641A (zh) *	2013-12-20	2016-08-03	雀巢产品技术援助有限公司	用于减少肠病原体的营养组合物
MA39710A (fr)	2014-04-23	2015-10-29	Sofar Spa	Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CN104187624B (zh) *	2014-08-07	2016-06-08	逯明福	综合营养粉及其制备方法
WO2016029113A1 (fr) *	2014-08-22	2016-02-25	Abbott Laboratories	Procédés d'augmentation de la production endogène de bêta-hydroxy-bêta-méthylbutyrate
WO2016053308A1 (fr)	2014-09-30	2016-04-07	Kimberly-Clark Worldwide, Inc.	Composition prébiotique synergique
KR101814967B1 (ko)	2014-09-30	2018-01-04	킴벌리-클라크 월드와이드, 인크.	크레이프된 프리바이오틱 티슈
CA2964480A1 (fr)	2014-10-31	2016-05-06	Whole Biome Inc.	Procedes et compositions se rapportant a un traitement microbien et au diagnostic de troubles
CN104432069A (zh) *	2014-12-22	2015-03-25	威海百合生物技术股份有限公司	一种肠胃通畅片
JP6338113B2 (ja) *	2015-03-31	2018-06-06	株式会社東洋新薬	除脂肪体重の増加剤
WO2017114686A1 (fr) *	2015-12-30	2017-07-06	Nestec S.A.	Procédé permettant de déterminer la masse corporelle sans graisse
US20190008195A1 (en) *	2015-12-31	2019-01-10	Nestec S.A.	Composition for improving mouthfeel
FI3639834T3 (fi) *	2016-02-04	2023-09-27	Univ Gent	Mikrobiyhteisöjen käyttö ihmisen ja eläimen terveyttä varten
EP3445857B1 (fr)	2016-04-20	2023-07-05	The Board of Trustees of the Leland Stanford Junior University	Compositions et procédés d'expression d'acide nucléique et sécrétion de protéine dans des bactéroïdes
IT201600083376A1 (it)	2016-08-08	2018-02-08	Sofar Spa	Uso di probiotici per aumentare l’assorbimento proteico
ITUA20164188A1 (it)	2016-06-08	2017-12-08	Sofar Spa	Nuovo uso medico di probiotici
US20180030403A1 (en)	2016-07-28	2018-02-01	Bobban Subhadra	Devices, systems and methods for the production of humanized gut commensal microbiota
CA3038061A1 (fr) *	2016-09-22	2018-03-29	The University Of Chicago	Modulation de reaction immunitaire au moyen de produits biotherapeutiques vivants, dans des conditions telles que la desensibilisation allergique
IT201600122724A1 (it)	2016-12-02	2018-06-02	Sofar Spa	Exopolysaccharides and uses thereof
AU2017376780B2 (en)	2016-12-15	2024-12-12	Novome Biotechnologies, Inc.	Compositions and methods for modulating growth of a genetically modified gut bacterial cell
IT201600127498A1 (it)	2016-12-16	2018-06-16	Sofar Spa	Probiotici per uso nella diverticolosi e malattia diverticolare
CN108245530A (zh) *	2016-12-28	2018-07-06	兰州奇正生态健康品有限公司	一种具有润肠通便作用的组合物及其制备方法与用途
ES2683014B1 (es) *	2017-03-23	2019-01-16	Cuetara S L	Galleta infantil sin azúcares añadidos
RU2740156C1 (ru)	2017-06-21	2021-01-12	Эбботт Лабораториз	Способы улучшения роста полезных бактерий в желудочно-кишечном тракте
AU2018318132B2 (en)	2017-08-14	2025-06-26	Seres Therapeutics, Inc.	Compositions and methods for treating cholestatic disease
WO2019046646A1 (fr)	2017-08-30	2019-03-07	Whole Biome Inc.	Methodes et compositions pour le traitement de troubles associés au microbiome
GB2566971B (en) *	2017-09-28	2020-12-02	Mjn Us Holdings Llc	Infant formula having decreased protein content
IT201700108033A1 (it)	2017-09-27	2019-03-27	Neilos S R L	Composizione per il trattamento della costipazione
IT201700108039A1 (it)	2017-09-27	2019-03-27	Neilos S R L	Composizione per il trattamento della costipazione
EP3466276A1 (fr)	2017-10-05	2019-04-10	Pharmactive Biotech Products, S.L.	Composition de fibres diététiques pour protéger des composés bioactifs pendant le processus de digestion physiologique
EP3703720A1 (fr)	2017-10-30	2020-09-09	Seres Therapeutics, Inc.	Compositions et méthodes de traitement d'une résistance aux antibiotiques
EP3704958A4 (fr) *	2017-10-31	2021-06-30	Morinaga Milk Industry Co., Ltd.	Composition pour augmentation de la masse musculaire
US11484547B2 (en) *	2018-01-08	2022-11-01	Performance Labs PTE. LTD.	Compositions and methods for cholesterol, glucose and microbiome control
JP7811843B2 (ja)	2018-07-19	2026-02-06	ペンデュラムセラピューティクス，インコーポレイテッド	微生物生着のための方法および組成物
US20200113858A1 (en)	2018-10-15	2020-04-16	Freedom Health, Llc	Human dietary supplement and method for treating digestive system and immune-related disorders
WO2020127630A1 (fr) *	2018-12-19	2020-06-25	Cosucra Groupe Warcoing S.A.	Composition comprenant de la fibre de racine de chicorée et de paroi cellulaire de pois pour traiter des infections par brachyspira
DE20708726T1 (de) *	2019-01-18	2022-01-13	Cp Kelco U.S., Inc.	Präbiotische zusammensetzung und deren verwendung
WO2020161522A1 (fr) *	2019-02-06	2020-08-13	Thd S.P.A.	Composition à base de fibres
FR3093427B1 (fr) *	2019-03-05	2021-03-05	Mativa Tech	Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
WO2020185857A1 (fr) *	2019-03-12	2020-09-17	The Board Of Regents Of The University Of Texas System	Scintigraphie de vidange gastrique et surveillance de glucose sanguin, simultanées
CN109820865A (zh) *	2019-04-09	2019-05-31	福州大学	低聚木糖和部分水解的瓜尔豆胶复配组合物在预防肥胖及保健品中的应用
JP7321503B2 (ja) *	2019-05-21	2023-08-07	フジ日本精糖株式会社	イヌリンを含む筋肉量減少抑制又は骨密度減少抑制剤
US20220248739A1 (en)	2019-05-29	2022-08-11	N.V. Nutricia	Non-digestible oligosaccharides for decreased colonic protein fermentation
CN114366826A (zh) *	2019-07-09	2022-04-19	大连大学	一种落叶松阿拉伯半乳聚糖组合物的制备方法及其灭菌处理装置
EP3988664B1 (fr) *	2019-08-30	2025-01-22	Hem Pharma Inc.	Procédé de criblage d'une substance personnalisée améliorant l'environnement intestinal à l'aide d'un procédé pmas
GB201915144D0 (en) *	2019-10-18	2019-12-04	Multigerm Uk Entpr Ltd	Method of promoting SCFA production by gut microbiota
US11751597B2 (en)	2019-11-05	2023-09-12	Alfasigma S.P.A.	Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN110679955A (zh) *	2019-11-11	2020-01-14	成都高新区九州华昀医疗美容门诊部有限公司	可改善肠道功能的大鲵活性肽营养组合物
EP4110087A1 (fr) *	2020-02-27	2023-01-04	Abbott Laboratories	Méthodes d'amélioration de la santé osseuse
WO2021207412A1 (fr)	2020-04-08	2021-10-14	Rutgers, The State University Of New Jersey	Préparations de mélange de fibres et leurs utilisations
JP2023522579A (ja) *	2020-04-24	2023-05-31	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	繊維及びマルベリーを含む組成物
CN111440841A (zh) *	2020-05-19	2020-07-24	爱礼康生物医药（苏州）有限公司	一种检测膳食纤维对人肠道菌活性影响的方法
EP4152961A1 (fr) *	2020-05-20	2023-03-29	Société des Produits Nestlé S.A.	Effet bénéfique de la fibre de poaceae et/ou de leguminoseae sur la survie et l'activité métabolique de bifidobacterium longum
AU2021281622A1 (en) *	2020-05-29	2022-12-01	Societe Des Produits Nestle Sa	Compositions and methods for digestive health in an animal
JP7688866B2 (ja) *	2020-07-14	2025-06-05	物産フードサイエンス株式会社	筋肉量率を増加させる剤および方法、ならびに体脂肪率を減少させる剤および方法
WO2022083858A1 (fr) *	2020-10-21	2022-04-28	Compagnie Gervais Danone	Gomme d'acacia pour une dysbiose microbienne induite par le fer
JP2022072243A (ja) *	2020-10-29	2022-05-17	帝人株式会社	腸内細菌叢改善用組成物及び腸内腐敗物質産生抑制用組成物
CN112715669A (zh) *	2020-11-24	2021-04-30	本溪木兰花乳业有限责任公司	一种改善便秘的牛奶制品及其制备方法
US20240058373A1 (en)	2020-12-09	2024-02-22	N.V. Nutricia	Fibre mixture for young children
EP4119135A1 (fr) *	2021-07-13	2023-01-18	Luxia Scientific	Methodes pour reequilibrer la flore intestinale chez les patients souffrant de la maladie de parkinson
US20240366654A1 (en) *	2021-07-16	2024-11-07	Purdue Research Foundation	Prebiotic composition and method of use to improve gastrointestinal health in patients with dysbiosis and leaky gut
CN113826892A (zh) *	2021-09-17	2021-12-24	潍坊易北特健康食品有限公司	一种基于肠道微生物调控特定胆汁酸的组合物及制备方法
WO2023054625A1 (fr) *	2021-09-29	2023-04-06	森永乳業株式会社	Composition contenant de l'acide thréonique et procédé pour la produire
JP2023055389A (ja) *	2021-10-06	2023-04-18	株式会社明治	バクテロイデス属細菌の増殖促進剤
CN114224925A (zh) *	2021-12-23	2022-03-25	广东格物生物科技有限公司	一种调节肠道健康的益生菌组合物及其制备方法
ES2955633A1 (es) *	2022-04-26	2023-12-04	Servicio Andaluz De Salud	Composición para la rehabilitación intestinal
CN115025116B (zh) *	2022-07-13	2023-11-21	纽湃腾（北京）医药科技有限公司	一种显著改善胃食管反流伴肠易激综合征的组合物及其应用
WO2025106584A1 (fr) *	2023-11-14	2025-05-22	Kate Farms, Inc.	Préparation pour nourrissons
GR1011003B (el) *	2024-02-28	2025-07-22	Cloudpharm Private Company,	Συμπληρωμα διατροφης για την αντιμετωπιση της απωλειας της οστικης πυκνοτητας (οστεοπενια)
WO2025262090A1 (fr) *	2024-06-18	2025-12-26	Dsm Ip Assets B.V.	Combinaison de caroténoïdes et d'inuline et utilisations correspondantes
CN118681027A (zh) *	2024-07-16	2024-09-24	广州医科大学附属第一医院（广州呼吸中心）	一种丁酸菊粉凝胶及其制备方法
US20260083772A1 (en) *	2024-09-26	2026-03-26	Kenvue Brands Llc	Powder compositions comprising fiber
CN121286706A (zh) *	2025-12-01	2026-01-09	仙乐健康科技股份有限公司	用于调整肠道菌群的组合物、营养组合物和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5952314A (en)	1994-04-01	1999-09-14	Demichele; Stephen Joseph	Nutritional product for a person having ulcerative colitis
EP0756828B2 (fr)	1995-08-04	2010-09-22	N.V. Nutricia	Composition nutritionnelle contenant des fibres diététiques
DK1010374T3 (da) *	1998-12-15	2005-11-21	Nestle Sa	Fiberblanding til enterale sammensætninger
EP1261355B1 (fr) *	2000-03-01	2004-12-01	Société des Produits Nestlé S.A.	Formulation de carbohydrate (adjuvant prebiotique) destine a augmenter une reponse immune
EP1175905A1 (fr) *	2000-07-24	2002-01-30	Societe Des Produits Nestle S.A.	Composition nutritive
US6592863B2 (en)	2000-08-22	2003-07-15	Nestec S.A.	Nutritional composition
EP1243273A1 (fr)	2001-03-22	2002-09-25	Societe Des Produits Nestle S.A.	Composition contenant un agent prebiotique pour le traitement d'inflammation et d'activation anormal des agents immunitaires non-spécifiques
GB0308104D0 (en) *	2003-04-08	2003-05-14	Novartis Nutrition Ag	Organic compounds
ITMI20040956A1 (it)	2004-05-12	2004-08-12	Curti Alessandro	Composizioni alimentari
EP1597978A1 (fr) *	2004-05-17	2005-11-23	Nutricia N.V.	Synergie de GOS et polyfructose
US8252769B2 (en)	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
CA2624921C (fr)	2005-10-05	2012-07-10	Nestec S.A.	Formulation nutritionnelle favorisant la croissance de rattrapage
ITMI20062031A1 (it)	2006-10-23	2008-04-24	Velleja Res Srl	Composizioni per la prevenzione del depauperamento della flora intestinale e del danno d'organo successivi a terapia antibiotica
EP2561766B1 (fr)	2006-11-07	2018-01-17	The Procter and Gamble Company	Compositions contenant des fibres et leurs procédés de fabrication et d'utilisation
ITMI20071214A1 (it) *	2007-06-15	2008-12-16	S I I T Srl Servizio Internazi	Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
DK2178385T4 (da)	2007-07-18	2022-01-31	Campina Nederland Holding Bv	Varmestabil næringsdrik og fremgangsmåde til fremstilling deraf
WO2009075564A1 (fr)	2007-12-10	2009-06-18	N.V. Nutricia	Mélange de fibres pédiatriques
JP5992654B2 (ja)	2007-12-21	2016-09-14	ニュートリー株式会社	整腸及び／又は便通改善のための組成物
JP6006117B2 (ja) *	2009-11-12	2016-10-12	ネステクソシエテアノニム	腸内微生物叢バランス及び健康を促進するための栄養組成物

2010
- 2010-11-11 JP JP2012538966A patent/JP6006117B2/ja active Active
- 2010-11-11 EP EP10779417.4A patent/EP2498626B1/fr not_active Revoked
- 2010-11-11 IN IN3632DEN2012 patent/IN2012DN03632A/en unknown
- 2010-11-11 RU RU2012123959/13A patent/RU2012123959A/ru not_active Application Discontinuation
- 2010-11-11 MX MX2012004778A patent/MX336032B/es unknown
- 2010-11-11 AU AU2010319490A patent/AU2010319490B2/en active Active
- 2010-11-11 BR BR112012011294-5A patent/BR112012011294B1/pt active IP Right Grant
- 2010-11-11 CN CN201410364998.3A patent/CN104206946A/zh active Pending
- 2010-11-11 ES ES10779417.4T patent/ES2545597T3/es active Active
- 2010-11-11 WO PCT/US2010/056321 patent/WO2011060123A1/fr not_active Ceased
- 2010-11-11 CA CA2777941A patent/CA2777941C/fr active Active
- 2010-11-11 DK DK10779417.4T patent/DK2498626T3/en active
- 2010-11-11 CN CN2010800498229A patent/CN102595934A/zh active Pending
- 2010-11-11 PH PH1/2012/500687A patent/PH12012500687A1/en unknown
- 2010-11-11 US US13/502,918 patent/US9192179B2/en active Active
2015
- 2015-10-20 US US14/887,497 patent/US10015978B2/en active Active
2016
- 2016-02-15 JP JP2016025895A patent/JP6205003B2/ja active Active

Also Published As

Publication number	Publication date
AU2010319490A1 (en)	2012-05-03
DK2498626T3 (en)	2015-07-13
JP6205003B2 (ja)	2017-09-27
WO2011060123A1 (fr)	2011-05-19
JP6006117B2 (ja)	2016-10-12
CA2777941C (fr)	2018-08-14
JP2013510865A (ja)	2013-03-28
US20120269865A1 (en)	2012-10-25
BR112012011294B1 (pt)	2018-03-20
CN102595934A (zh)	2012-07-18
CN104206946A (zh)	2014-12-17
ES2545597T3 (es)	2015-09-14
PH12012500687A1 (en)	2012-10-29
US9192179B2 (en)	2015-11-24
US10015978B2 (en)	2018-07-10
BR112012011294A2 (pt)	2015-09-15
MX2012004778A (es)	2012-06-01
CA2777941A1 (fr)	2011-05-19
US20160100617A1 (en)	2016-04-14
EP2498626B1 (fr)	2015-06-17
MX336032B (es)	2016-01-07
RU2012123959A (ru)	2013-12-20
HK1172516A1 (en)	2013-04-26
JP2016166176A (ja)	2016-09-15
EP2498626A1 (fr)	2012-09-19
AU2010319490B2 (en)	2015-03-19

Publication	Publication Date	Title
MX336032B (es)	2016-01-07	Composicion nutricional para promover el balance y salud de la microbiota intestinal.
NZ602249A (en)	2014-10-31	Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
SG170090A1 (en)	2011-04-29	Immunogenic composition
WO2006110406A3 (fr)	2007-07-12	Compositions comprenant des composants probiotiques et des composants edulcorants
MX2010005424A (es)	2010-06-01	Proceso de recubrimiento particulado.
WO2011056487A3 (fr)	2011-07-07	Formulations stables d'épaississant
TNSN07360A1 (en)	2008-12-31	Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX360480B (es)	2018-11-05	Composiciones alimenticias tipo barra.
MY158319A (en)	2016-09-30	Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
MX2011012297A (es)	2012-04-19	Mejoramiento de la salud gastrointestinal, la inmunidad y el rendimiento mediante intervención dietética.
PH12012502159A1 (en)	2013-02-04	Pharmaceutical compositions and methods of making same
MY150082A (en)	2013-11-29	Trans-clomiphene for metabolic syndrome
MX2019012939A (es)	2019-12-16	Formulaciones que contienen linaclotida para administracion oral.
MX351037B (es)	2017-09-28	Composiciones de goma humectantes de la boca y productos que contienen las mismas.
PT2197456E (pt)	2011-05-18	Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico
NZ600094A (en)	2014-10-31	Method of enhancing muscle protein synthesis
NZ605147A (en)	2014-12-24	Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
MX2010000266A (es)	2010-05-03	Un método para disminuir los síntomas del consumo de alcohol.
MX2009004847A (es)	2009-06-22	Composiciones que contienen fibra y metodos para elaborarlas y usarlas.
WO2008073764A3 (fr)	2009-07-30	Fluorescéine sensiblement pure
MY175195A (en)	2020-06-15	Nutritional compositions
MX342947B (es)	2016-10-18	Tratamiento de diabetes tipo 2.
HRP20231090T1 (hr)	2024-01-05	Pripravci i metode sinergističkog tretmana glikokaliksa
IN2011KN05169A (fr)	2015-07-17
MX2011007288A (es)	2011-09-09	Trozos en composicones alimenticias gelatinosas.